AR041954A1 - Un proceso para preparar acetato de risperidona y compuestos intermediarios para dicho proceso - Google Patents
Un proceso para preparar acetato de risperidona y compuestos intermediarios para dicho procesoInfo
- Publication number
- AR041954A1 AR041954A1 ARP030104179A ARP030104179A AR041954A1 AR 041954 A1 AR041954 A1 AR 041954A1 AR P030104179 A ARP030104179 A AR P030104179A AR P030104179 A ARP030104179 A AR P030104179A AR 041954 A1 AR041954 A1 AR 041954A1
- Authority
- AR
- Argentina
- Prior art keywords
- intermediate compounds
- oxime
- isomers
- acetate
- prepare
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/56—Nitrogen atoms
- C07D211/58—Nitrogen atoms attached in position 4
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
El proceso de formación de risperidona es mejorado mediante el uso de un compuesto intermedio (o varios compuesto intermedios) que es(son) una oxima de grupo fórmula (1) enriquecida en isómeros Z. La(s) oxima(s) puede(n) ser enriquecida(s) isoméricamente mediante una variedad de técnicas, incluyendo el uso de una nueva sal de ácido acético de la(s) misma(s), que provee, Inter. alia, la resolución de los isómeros, y/o mediante conversión térmica.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US42572702P | 2002-11-13 | 2002-11-13 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR041954A1 true AR041954A1 (es) | 2005-06-01 |
Family
ID=32313043
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP030104179A AR041954A1 (es) | 2002-11-13 | 2003-11-13 | Un proceso para preparar acetato de risperidona y compuestos intermediarios para dicho proceso |
Country Status (9)
Country | Link |
---|---|
US (2) | US7405298B2 (es) |
EP (1) | EP1560814A1 (es) |
CN (1) | CN100390146C (es) |
AR (1) | AR041954A1 (es) |
AU (1) | AU2003288017A1 (es) |
HR (1) | HRP20050424A2 (es) |
NO (1) | NO20052859L (es) |
WO (1) | WO2004043923A1 (es) |
ZA (1) | ZA200503698B (es) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ZA200603113B (en) * | 2003-09-26 | 2007-08-29 | Jubilant Organosys Ltd | Process for the preparation of risperidone |
WO2009077551A1 (en) * | 2007-12-18 | 2009-06-25 | Janssen Pharmaceutica Nv | Process for preparing risperidone |
US8772345B2 (en) | 2011-08-03 | 2014-07-08 | Southwest Research Institute | Oximes for treatment of peripheral and central nervous system exposure to acetyl cholinesterase inhibitors |
US8653108B1 (en) | 2011-08-03 | 2014-02-18 | Southwest Research Institute | Oximes for treatment of peripheral and central nervous system exposure to acetyl cholinesterase inhibitors |
US9162983B2 (en) | 2013-05-22 | 2015-10-20 | Southwest Research Institute | Reactivators of organophosphorous inhibited acetylcholinesterase |
CN104557918A (zh) * | 2014-12-12 | 2015-04-29 | 瑞阳制药有限公司 | 苯并异恶唑类抗精神病药利培酮的制备方法 |
CN107422055A (zh) * | 2017-07-27 | 2017-12-01 | 天津药物研究院药业有限责任公司 | 一种利培酮原料或制剂中杂质的检测方法 |
CN108445101B (zh) * | 2018-03-16 | 2021-01-01 | 安徽新世纪药业有限公司 | 一种利培酮口服溶液有关物质的检测方法 |
CN109438443A (zh) * | 2018-12-24 | 2019-03-08 | 浙江工业大学上虞研究院有限公司 | 利培酮的制备方法 |
CN111777601B (zh) * | 2020-05-23 | 2021-07-16 | 白银京宇新药业有限公司 | 一种6-氟-3-(4-哌啶基)-1,2苯并异噁唑盐酸盐的制备方法 |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3946022A (en) * | 1974-03-04 | 1976-03-23 | Richardson-Merrell Inc. | Piperidine derivatives |
US4335127A (en) | 1979-01-08 | 1982-06-15 | Janssen Pharmaceutica, N.V. | Piperidinylalkyl quinazoline compounds, composition and method of use |
US4342870A (en) | 1980-03-28 | 1982-08-03 | Janssen Pharmaceutica N.V. | Novel 3-(1-piperidinylalkyl)-4H-pyrido[1,2-a]pyrimidin-4-one derivatives |
US4408054A (en) * | 1981-11-12 | 1983-10-04 | Hoechst-Roussel Pharmaceuticals Inc. | Oximes of 4-benzoyl-piperidines |
US4804663A (en) | 1985-03-27 | 1989-02-14 | Janssen Pharmaceutica N.V. | 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles |
CA2000786C (en) | 1988-11-07 | 1999-01-26 | Cornelus G. M. Janssen | 3-piperidinyl-1,2-benzisoxazoles |
GB9008850D0 (en) | 1990-04-19 | 1990-06-13 | Janssen Pharmaceutica Nv | Novel 2,9-disubstituted-4h-pyridol(1,2-a)pyrimidin-4-ones |
ES2050069B1 (es) * | 1992-07-10 | 1994-12-16 | Vita Invest Sa | Procedimiento para la obtencion de 3-(2-(4-(6-fluoro-1,2-benzisoxazol-3-il)piperidino)etil)-2-metil-6,7,8,9-tetrahidro-4h-pirido(1,2-a) pirimidin-4-ona. |
ES2074966B1 (es) | 1994-02-11 | 1996-06-16 | Vita Invest Sa | Procedimiento para la obtencion de 3-(2-(4-(6-fluoro-benzo(d)isoxazol-3-il)piperidin-1-il)-etil)-2-metil-6,7,8,9-tetrahidro-4h-pirido-(1,2-a)pirimidin-4-ona. |
WO2001085731A1 (en) | 2000-05-05 | 2001-11-15 | Rpg Life Sciences Limited | A PROCESS FOR THE PREPARATION OF ANTI-PSCHOTIC 3-[2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2,-a]pyrimidin-4-one |
WO2002012200A1 (en) | 2000-08-08 | 2002-02-14 | Teva Pharmaceutical Industries Ltd. | Preparation of risperidone |
ES2310410T3 (es) | 2000-08-14 | 2009-01-01 | Teva Pharmaceutical Industries Ltd. | Preparacion de risperidona. |
HU227118B1 (en) | 2001-11-13 | 2010-07-28 | Egis Gyogyszergyar Nyilvanosan | Process for the preparation of 3-{2-[4-(6-fluoro-1,2-benzizoxazol-3-yl)-1-piperidinyl]-ethyl}-6,7,8,9-tetrahydro-2-methyl-4h-pyrido[1,2-a]pyrimidin-4-one |
CA2551346A1 (en) * | 2003-12-31 | 2005-07-21 | Warner-Lambert Company Llc | N-substituted piperidine and piperazine derivatives |
-
2003
- 2003-11-07 EP EP03779870A patent/EP1560814A1/en not_active Withdrawn
- 2003-11-07 AU AU2003288017A patent/AU2003288017A1/en not_active Abandoned
- 2003-11-07 CN CNB2003801049621A patent/CN100390146C/zh not_active Expired - Fee Related
- 2003-11-07 WO PCT/EP2003/012504 patent/WO2004043923A1/en not_active Application Discontinuation
- 2003-11-13 AR ARP030104179A patent/AR041954A1/es unknown
- 2003-11-13 US US10/705,926 patent/US7405298B2/en not_active Expired - Fee Related
-
2005
- 2005-05-09 ZA ZA200503698A patent/ZA200503698B/en unknown
- 2005-05-12 HR HR20050424A patent/HRP20050424A2/xx not_active Application Discontinuation
- 2005-06-13 NO NO20052859A patent/NO20052859L/no not_active Application Discontinuation
-
2008
- 2008-06-18 US US12/141,596 patent/US20080262227A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
NO20052859L (no) | 2005-08-05 |
AU2003288017A1 (en) | 2004-06-03 |
NO20052859D0 (no) | 2005-06-13 |
EP1560814A1 (en) | 2005-08-10 |
CN1720228A (zh) | 2006-01-11 |
CN100390146C (zh) | 2008-05-28 |
US20080262227A1 (en) | 2008-10-23 |
HRP20050424A2 (en) | 2006-08-31 |
US7405298B2 (en) | 2008-07-29 |
ZA200503698B (en) | 2006-08-30 |
WO2004043923A1 (en) | 2004-05-27 |
US20040097523A1 (en) | 2004-05-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR040773A1 (es) | Pirazoles utiles como inhibidores de gsk-3 | |
SE0103046D0 (sv) | Kristallin bas av citalopram | |
WO2003062259A3 (en) | Non-aromatic 17.alpha.-esters of androstane-17.beta.-carboxylate esters as anti-inflammatory agents | |
AR039789A1 (es) | Pirazolopiridinas sustituidas con carbamato | |
AR085778A2 (es) | Forma de dosis solida enterica revestida, que comprende acido micofenolico o sal micofenolato | |
EA200201056A1 (ru) | Новые, обладающие продолжительным действием бетамиметики, способ их получения и их применение в качестве лекарственных средств | |
AR041954A1 (es) | Un proceso para preparar acetato de risperidona y compuestos intermediarios para dicho proceso | |
AR036100A1 (es) | Derivados de naftil benzofurano sustituidos, composiciones farmaceuticas y el uso de dichos derivados para la manufactura de medicamentos que son inhibidores del inhibidor-1 activador de plasminogeno (pai-1) | |
CO5720995A2 (es) | Compuesto novedoso | |
NI201100211A (es) | Método mejorado para sintetizar pirfenidona | |
ATE411793T1 (de) | Topische leave-on zusammensetzung enthaltend spezifische pantothensäure-derivate | |
RU92016217A (ru) | Двойные ингибиторы no синтазы и циклооксигеназы, способ их получения и фармацевтическая композиция на их основе | |
ATE554062T1 (de) | Verfahren zur herstellung von alkylierten salicylamiden durch ein dicarboxylat- zwischenprodukt | |
AR032360A1 (es) | Compuesto derivado de acido homoiminopiperidinil hexanoico, composicion farmaceutica que lo comprende y compuestos intermediarios que se usan en su preparacion | |
ECSP045221A (es) | Sales de valsartan | |
RU93005334A (ru) | Производные стероидов для лечения гипертрофии предстательной железы, способ их получения, использование, фармкомпозиция | |
DE50304030D1 (de) | Verfahren zur Herstellung von 5-Nitrobenzofuranen | |
AR078318A1 (es) | Compuestos carbonatos de anti-biopelicula para su uso en composiciones de cuidado oral | |
PA8572001A1 (es) | Derivados de isoquinolina | |
AR043430A1 (es) | Derivados de diarilcicloalquilo, procesos para su preparacion y su uso como agentes farmaceuticos | |
AR039935A1 (es) | Formulacion farmaceutica de liberacion inmediata | |
AR036176A1 (es) | Un derivado de fenil-acetamido-tiazol, un procedimiento para su preparacion, una composicion farmaceutica que lo comprende, un producto o kit que los comprende, y un metodo que utiliza dicho derivado | |
NO20040388L (no) | Fremgangsmåte for fremstilling av beraprost og salter derav, samt forbindelser som er mellomprodukter i fremgangsmåten | |
UY28688A1 (es) | Derivados de amida | |
ES2183492T3 (es) | Nuevos derivados de nitrono,su procedimiento de preparacion y las composiciones farmaceuticas que los contienen. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |